1. Angelini Pharma
  2. Core areas
  3. Epilepsy

Epilepsy

AP22 Site 1030X302 Brainhealth

Angelini's commitment to epilepsy 

Please read more about our commitment to epilepsy at HarmoniaMentis.co.uk.

 

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card System at www.MHRA.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. By reporting side effects you can help provide more information on the safety of this medicine.

If you are a patient or healthcare professional and need to report an adverse event or have a product complaint, please contact Angelini Pharma on (UK) UKIReporting@angelinipharma.com